British doc calls for boys to get HPV vaccines; Dendreon receives EU approval boost;

> A leading British doctor has called for boys to receive HPV vaccines. Article

> Dendreon ($DNDN) has received approval to market Provenge in Europe. News

> The NYT has taken a closer look at last week's preclinical HIV vaccine success. Feature (sub. req.)

> Genocea has reported positive interim data from a trial of its herpes vaccine. Item

> Profectus BioSciences has begun a Phase I clinical trial of its HIV vaccine. Article

> A Cleveland Clinic spinout has raised cash to advance a breast cancer vaccine into the clinic. Piece

> Bangladesh has doubled its vaccine storage capacity ahead of introducing a pneumococcal shot. Item

> Panacea Biotec has reportedly received WHO prequalification for its pentavalent vaccine. News

And Finally... The Indian Academy of Pediatrics has defended the safety of the pentavalent vaccine. Piece

Suggested Articles

CEPI, which started to help prepare the world for new outbreaks, has awarded Inovio and Moderna money for vaccine work against the new coronavirus.

As a new coronavirus spreads, vaccine researchers have started work on candidates against the virus—and one could enter the clinic in a few months.

Merck's HPV vaccine Gardasil is delivering blockbuster sales as demand surges. But high demand has caused somewhat of a supply constraint.